Examining Facility Level Data

Similar documents
Dialysis outcomes: can we do better?

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM

morbidity & mortality

Chapter 10: Dialysis Providers

FIRST RENAL REPLACEMENT

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly?

Chapter 9: Cardiovascular Disease in Patients With ESRD

University of Michigan School of Public Health

Comparison of mortality with home hemodialysis and center hemodialysis: A national study

REIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange

Chapter 8: Cardiovascular Disease in Patients with ESRD

Chapter 6: Mortality. Introduction 2016 USRDS ANNUAL DATA REPORT VOLUME 2 ESRD IN THE UNITED STATES

2008 Dialysis Facility Report

Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes

METABOLISM AND NUTRITION WITH PD OBESITY. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle

State Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE

2010 Dialysis Facility Report

2011 Dialysis Facility Report

Status of the CKD and ESRD treatment: Growth, Care, Disparities

2011 Dialysis Facility Report SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE Dialysis Facility Report SAMPLE

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Chapter Five Clinical indicators & preventive health

Measure Information Form

Chapter 2: Identification and Care of Patients With CKD

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

MORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS

PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD

Who? Dialysis for Acute Renal Failure: Who, What, How, and When? Kathleen D. Liu, MD, PhD, MAS June 2011

Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system

Introduction to Volume 2: ESRD in the United States

Costs and effectiveness of cardiac rehabilitation for dialysis patients following coronary bypass

Supplementary Online Content

What Happened? 3/20/2017. Changing Lives and Making a Difference: Home Hemodialysis Stories. Brigitte Schiller, MD, FACP, FASN

04 Chapter Four Treatment modalities. Experience does not err, it is only your judgement that errs in expecting from her what is not in her power.

USRDS UNITED STATES RENAL DATA SYSTEM

Lesson #7: Quality Assessment and Performance Improvement

Variable Included. Excluded. Included. Excluded

Understanding Dialysis Facility Compare: Driving Informed Decision Making

Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access

Chapter 25: Interactions of Dialysis Teams With Geriatricians

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease

Chapter 2: Identification and Care of Patients with CKD

TITLE: First Initiative Peritoneal Dialysis versus Hemodialysis for the Treatment of Renal Failure: A Review of Clinical Effectiveness and Guidelines

Transition between home dialysis modalities another piece in the jigsaw of the integrated care pathway.

RRT and conservative management

rehabilitation/quality of life & nutrition special studies

WHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington

Andrea Pizutti, LCSW Gayle Hall, BSN, RN, CNN Regional Operations Director Area Director Davita NxStage Kidney Care

Surveillance and Prevention of NCDs : Applying LHS Principles to Kidney Disease

02/27/2018. What is a Physician Home Champion? What skills does a home champion need to have?

A population-based approach indicates an overall higher patient mortality with peritoneal dialysis compared to hemodialysis in Korea

Using the Knowledge to Action Cycle to Improve Timing of dialysis initiation

MEASURE INFORMATION FORM

Chapter 2: Identification and Care of Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD

The vexing problem of suboptimal initiation of dialysis: Can we do better?

Association between causes of peritoneal dialysis technique failure and all-cause mortality

Dialysis Dose and Body Mass Index Are Strongly Associated with Survival in Hemodialysis Patients

2012 Dialysis Facility Report

Quarterly Dialysis Facility Compare - Preview for April 2018 Report DFC Dialysis Facility State: XX Network: 99 CCN: SAMPLE

Chapter 5: Acute Kidney Injury

Measure Information Form

for comorbid conditions

KDIGO LESSONS LEARNED FROM NEPHROLOGY TRIALS WITH RESPECT TO HEART FAILURE

Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA

Dialysis modality and 2-year outcomes in patients with ischemic cardiomyopathy and end-stage renal disease

Internal Medicine Dialysis Provider Perspective Joe Ghata

ASDIN 7th Annual Scientific Meeting

MEASURE INFORMATION FORM

The outcomes of continuous ambulatory and automated peritoneal dialysis are similar

Time to Reduce Mortality in End Stage Renal Disease (TiME)

The case for daily dialysis: its impact on costs and quality of life Mohr P E, Neumann P J, Franco S J, Marainen J, Lockridge R, Ting G

Arches National Park, Utah. hospitalization

United States Renal Data System (USRDS) International Data Collection Form

Chapter 1: Incidence, Prevalence, Patient Characteristics, and Treatment Modalities

Perspectives on the New Kidney Disease Education Benefit: Early Awareness, Race and Kidney Transplant Access in a USRDS Study

Comparing Mortality of Peritoneal and Hemodialysis Patients in the First 2 Years of Dialysis Therapy: A Marginal Structural Model Analysis

Chapter 6: Healthcare Expenditures for Persons with CKD

FULFILLMENT OF K/DOQI GUIDELINES 92 anemia treatment dialysis therapy vascular access

Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009

Section K. Economic costs of ESRD. Vol 3 esrd. pg 731. K tables

KDOQI Guidelines. Overview. Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium

RCC in ADPKD / CKD / ESRD

MEASURE INFORMATION FORM

Agenda CIAHD Monthly Research Meeting SPH Tower 1, Room 4645 February 3, :30 3:00pm. I. Meeting Overview 5 minutes

Evidence Table. Study Type: Randomized controlled trial. Study Aim: To compare frequent nocturnal hemodialysis and conventional in-center dialysis.

Impact of Timing of Initiation of Dialysis on Mortality

Management of End Stage Renal Disease-Bangladesh Perspective

Management of the Frail Older Patients: What Are the Outcomes

Experts in all modalities The Expanding Role of PD Trends and Advances That Have Increased the Viability and Utilization of Peritoneal Dialysis

Chapter IV. Patient Characteristics at the Start of ESRD: Data from the HCFA Medical Evidence Form

The CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES

David C. Mendelssohn MD, FRCPC DOPPS Update 2010

USRDS UNITED STATES RENAL DATA SYSTEM

KIDNEY TRANSPLANTATION IS THE

CHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA

AJNT. Original Article

Transcription:

Examining Facility Level Data for the USRDS Yi Li, PhD Professor of Biostatistics, University of Michigan, Ann Arbor Director, Kidney Epidemiology and Cost Center (KECC) Co Deputy Director, United States Renal Data System Coordinating Center

Disclosures Federal funding sources National Institutes of Health NIDDK and NCI Centers for Medicare & Medicaid Services Centers for Disease Control and Prevention Veterans Health Administration Non federal funding sources Joint Institute (University of Michigan and Beijing University) 2

Initial Modality Peritoneal Dialysis (PD) and Hemodialysis (HD) About 90% of ESRD patients started with HD, while 10% started with PD However, some argue that the predominance of HD as initial therapy has little to do with clinical outcomes, but is driven by ease of HD initiation (Ghaffari et al., 2013) There is an increasing trend of PD usage (ADR, 2014) and more interest in starting dialysis with PD 3

Should We Start with PD? PD preserves residual renal function and vascular access sites, lowers cost of therapy, and offers better patient autonomy compared with HD (Dalal et al., 2011) PD is not associated with myocardial stunning, as opposed to HD (Selby and McIntyre, 2011) 4

Some Studies Comparing PD versus HD Publication Lukowsky et. al (2013) Weinhandl et. al (2010) Mehrotra et. al (2010) Vonesh et. al (2004) No. of Patients (duration of study) 23,718 (2001 2006) 98,875 (2003) 684,426 (1996 2004) 398,340 (1995 2000) Hazard Ratio (PD vs HD) Follow up Time Statistical Methodology 0.52 2 years Marginal structural model 0.92 4 years Propensity score 1.03~1.08 5 years Propensity score Varies by subgroups 3 years Covariate adjustment 5

Our Goals and Methods Utilize the most recent USRDS data to study the effect of initial dialysis modality on patients early mortality Explore various statistical approaches to compare early survival outcomes in an observational setting descriptive analysis covariate adjustment propensity score instrumental variable All analyses are conducted under intent to treat 6

Study Population 2010 2012 Incident Patients 310,496 adult dialysis patients 6,109 dialysis facilities 296,531 patients w/ complete information 5,771 facilities 294,346 patients at facilities with 10+ patients 5,292 facilities 270,342 patients survived 90 days 5,292 facilities 7

Weekly Mortality Rate 2010 2012 incident patients 8

Comparisons of Patient Characteristics by Initial Modality Patient characteristic Hemodialysis Peritoneal Dialysis Age (M) 64.3 59.0 Black (%) 28.4 22.7 Nephrology care >6 months (%) 42.1 67.2 egfr (M) 11.7 11.2 Diabetes (%) 60.4 53.0 CAD (%) 20.2 13.4 PAD (%) 13.4 8.5 Number of comorbidities* (M) 1.9 1.4 *Excluding CAD, PAD and diabetes. 9

Distribution of Facility Level PD Usage (2012) Among facilities with any PD patients (51% of all facilities) 10

Weekly Mortality Rate Patient Age 11

Weekly Mortality Rate Race 12

Weekly Mortality Rate Patient Health Status Healthier: Less Healthy: < 65 years old, no diabetes, no coronary artery disease (CAD) or peripheral artery disease (PAD) > 65, diabetes, either CAD or PAD 13

Weekly Mortality Rate Pre ESRD Nephrologist Care HD PD 14

Crude Comparison of PD vs HD in Early Mortality Day 0 90 (n = 294,346) Day 91 365 (n = 270,342) Hazard Ratio 0.23 0.41 95% Confidence Interval 0.21 0.26 0.39 0.44 15

Potential Issues Differences in patient level and facility level characteristics among the treatment groups Unobserved confounders could also render bias 16

Statistical Approach Propensity Score Aims to create a pseudo randomized trial setting by accounting for the covariates that predict treatment assignment Balances comparison groups on a large number of covariates without losing many observations One main disadvantage is that it only accounts for observed (and observable) covariates 17

Statistical Approach Instrumental Variable (IV) Accounts for unobserved confounders Selection of instrumental variables depends on subject matter knowledge, and weak instruments cause instability 18

Average PD Usage of Other Patients in Facilities as IV Represents the facility preference of PD usage Possibly independent of unmeasured patient related confounders (conditional on measured covariates) Fairly strong instrument (i.e., the large variation of PD usage across facilities) 19

Comparisons of PD and HD in Early Mortality Estimates from Competing Methods Day 0 90 (n = 294,346) Hazard Ratio (95% CI) Day 91 365 (n = 270,342) Hazard Ratio (95% CI) Crude 0.23 (0.21, 0.26) 0.41 (0.39, 0.44) Covariate adjusted 0.40 (0.37, 0.44) 0.62 (0.59, 0.65) Propensity score 0.38 (0.34, 0.42) 0.63 (0.59, 0.66) Instrumental variable 0.39 (0.34, 0.45) 0.62 (0.57, 0.67) 20

Comparisons of PD and HD in Early Mortality Subgroup Analysis Healthier (Age 65, no diabetes, CAD or PAD) Day 0 90 (n = 44,792) Day 91 365 (n = 42,601) Crude 0.09 (0.06, 0.14) 0.21 (0.17, 0.44) Covariate adjusted 0.19 (0.13, 0.27) 0.34 (0.28, 0.42) Propensity score (stratified) 0.21 (0.12, 0.36) 0.32 (0.24, 0.44) Instrumental variable 0.18 (0.11, 0.30) 0.29 (0.21, 0. 40) Less Healthy (Age 65, diabetes and either CAD or PAD) (n = 53,424) (n = 46,879) Crude 0.41 (0.34, 0.49) 0.68 (0.61, 0.76) Covariate adjusted 0.56 (0.47, 0.66) 0.83 (0.75, 0.91) Propensity score (stratified) 0.53 (0.44, 0.63) 0.83 (0.75, 0.91) Instrumental variable 0.51 (0.38, 0.70) 0.89 (0.74, 1.08) 21

Summary There is an increasing trend of PD usage recently There is a mortality peak around 6 weeks among the initial HD group, while no obvious peaks are found among the initial PD group Different approaches hint at early survival advantages of initial PD, and these advantages differ by subgroups Statistical approaches are useful for the analysis of observational data, although more effort is needed to verify certain assumptions Accounting for duration of PD usage and modality switch is an ongoing project 22

Should Peritoneal Dialysis as Initial Modality Become a Standard of Care? Patient education Bundled payment Technique failure Patient satisfaction 23

Acknowledgments Hui Liu Rajiv Saran Doug Lehmann Yun Li Deanna Chyn Amy Jiao Tempie Shearon Anca Tilea Valarie Ashby 24

Distribution of Propensity Scores, by Modality 25

Facility Level PD Usage, by Facility Characteristics Size Median* Income Median* Education Profit Status * Median for each facility s ZIP code. Education represents the median percentage of bachelor s degrees in the ZIP code. 26